Intravenous injection of some liposomal drugs, diagnostic agents, micelles and other lipid-based nanoparticles can cause acute hypersensitivity reactions (HSRs) in a high percentage (up to 45%) of patients, with hemodynamic, respiratory and cutaneous manifestations. The phenomenon can be explained with activation of the complement (C) system on the surface of lipid particles, leading to anaphylatoxin (C5a and C3a) liberation and subsequent release reactions of mast cells, basophils and possibly other inflammatory cells in blood. These reactions can be reproduced and studied in pigs, dogs and rats, animal models which differ from each other in sensitivity and spectru
Administration of liposome- and polymer-based clinical nanomedicines, as well as many other proposed...
Trimellitic anhydride (TMA) is one of many low molecular weight compounds known to cause occupationa...
Cardio-vascular diseases are the main cause of death, emphasizing the need to improve patient treat...
Intravenous administration of low (milligram) doses of nanoparticulate materials in pigs can lead to...
Pigs are known to provide a sensitive model for studying complement (C) activation-related pseudoall...
Pigs are known to provide a sensitive model for studying complement (C) activation-related pseudoall...
Polyethylene glycol (PEG)-coated nanopharmaceuticals can cause mild to severe hypersensitivity react...
Complement activation-related pseudoallergy (CARPA) is a hypersensitivity reaction to intravenous ad...
Hypersensitivity reactions to liposomal drugs, often observed with Doxil and AmBisome, can arise fro...
Liposomes are known to activate the complement (C) system, which can lead in vivo to a hypersensitiv...
The complement (C) activating effect of zymosan and liposomal drugs (AmBisome, Caelyx) leads to sign...
Infusion of PEGylated liposomes can give rise to hypersensitivity reactions (HSRs) in a relatively l...
Erik Őrfi,1,2 Tamás Mészáros,1,2 Mark Hennies,3 Tamás Fülöp,1,...
The increasing use of nanotechnologies in advanced therapies has allowed the observation of specific...
Intravenous administration of liposomal drugs can entail infusion reactions, also known as hypersens...
Administration of liposome- and polymer-based clinical nanomedicines, as well as many other proposed...
Trimellitic anhydride (TMA) is one of many low molecular weight compounds known to cause occupationa...
Cardio-vascular diseases are the main cause of death, emphasizing the need to improve patient treat...
Intravenous administration of low (milligram) doses of nanoparticulate materials in pigs can lead to...
Pigs are known to provide a sensitive model for studying complement (C) activation-related pseudoall...
Pigs are known to provide a sensitive model for studying complement (C) activation-related pseudoall...
Polyethylene glycol (PEG)-coated nanopharmaceuticals can cause mild to severe hypersensitivity react...
Complement activation-related pseudoallergy (CARPA) is a hypersensitivity reaction to intravenous ad...
Hypersensitivity reactions to liposomal drugs, often observed with Doxil and AmBisome, can arise fro...
Liposomes are known to activate the complement (C) system, which can lead in vivo to a hypersensitiv...
The complement (C) activating effect of zymosan and liposomal drugs (AmBisome, Caelyx) leads to sign...
Infusion of PEGylated liposomes can give rise to hypersensitivity reactions (HSRs) in a relatively l...
Erik Őrfi,1,2 Tamás Mészáros,1,2 Mark Hennies,3 Tamás Fülöp,1,...
The increasing use of nanotechnologies in advanced therapies has allowed the observation of specific...
Intravenous administration of liposomal drugs can entail infusion reactions, also known as hypersens...
Administration of liposome- and polymer-based clinical nanomedicines, as well as many other proposed...
Trimellitic anhydride (TMA) is one of many low molecular weight compounds known to cause occupationa...
Cardio-vascular diseases are the main cause of death, emphasizing the need to improve patient treat...